Last reviewed · How we verify
NCT04999150
Comparison of Corticotomy and Micro-Osteoperforation During Canine Retraction
NA trial testing Micro-Osteoperforations in Malocclusion, Class I/II in 13 participants. Completed in 26 September 2020.
11 July 2019
Quick facts
| Lead sponsor | University of Puerto Rico |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 13 |
| Start date | 2 October 2018 |
| Primary completion | 11 July 2019 |
| Estimated completion | 26 September 2020 |
| Sites | 1 location across Puerto Rico |
Drugs / interventions tested
- Micro-Osteoperforations
- Corticotomy
Conditions studied
- Malocclusion, Class I/II — all drugs for Malocclusion, Class I/II →
Sponsor
University of Puerto Rico
Who can join
Adults 12 to 45, any sex, with Malocclusion, Class I/II. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Corticotomy and micro-osteoperforation (MOP) have been proven to accelerate tooth movement and shorten orthodontic treatment time, compared to conventional treatment. MOP is less invasive; however, it is unclear whether it is as effective as a corticotomy. The purpose of this study was to compare the maxillary canine retraction achieved by these techniques.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04999150
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Malocclusion, Class I/II
Currently open trials in the same condition.
- NCT07038902 — A Comparative Study Between Modified Miniscrew-Assisted Rapid Palatal Expander And Modified Rapid Palatal Expander in Mo · NA · active not recruiting
Other University of Puerto Rico trials
Trials by the same sponsor.
- NCT06425510 — Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas · NA · not yet recruiting
- NCT07369102 — Esketamine With or Without Integration Therapy for Treatment-Resistant Depression · Phase 4 · recruiting
- NCT07039266 — Food Allergy Registry and Awareness Campaign in Puerto Rico · not yet recruiting
- NCT06917118 — Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control · NA · not yet recruiting
- NCT05910749 — Substance Use Disorder, Brain and Behavioral Regulation · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04999150 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Puerto Rico
- Last refreshed: 17 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04999150.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing